Adaptive Phage Therapeutics raises $7M for pathogen therapy

A Gaithersburg biotechnology firm developing a drug to fight multi-drug resistant disease-causing bacteria raised roughly $7 million in a financing effort.

To purchase a reprint of this article, contact reprints@thedailyrecord.com.

Leave a Reply

Your email address will not be published. Required fields are marked *